Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ko

Showing results (601-610 of 631) with videos related to

Pageof 64
Sort By:
Current Oncology (Toronto, Ont.)|February 14, 2014
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statementP J Karanicolas, P Metrakos, K Chan, et al.
Oncogene|October 15, 2013
HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptaseC-H Tsai, C-H Teng, Y-T Tu, et al.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 30, 2021
Care transitions and social needs: A Geriatric Emergency care Applied Research (GEAR) Network scoping review and consensus statementCameron J Gettel, Corrine I Voils, Alycia A Bristol, et al.
Oncogene|April 4, 2017
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasisC-J Ko, S-W Lan, Y-C Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancerB M Wolpin, E M O'Reilly, Y J Ko, et al.
Physical Review Letters|February 6, 2025
First Direct Search for Light Dark Matter Using the NEON Experiment at a Nuclear ReactorJ J Choi, C Ha, E J Jeon, et al.
Clinical Genitourinary Cancer|July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial designG R Pond, J Bellmunt, J E Rosenberg, et al.
Nature Communications|January 5, 2021
Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASHJinrui Dong, Sivakumar Viswanathan, Eleonora Adami, et al.
Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.
Pageof 64

Showing results (601-610 of 631) with videos related to

Sort By:
Pageof 64
Current Oncology (Toronto, Ont.)|February 14, 2014
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statementP J Karanicolas, P Metrakos, K Chan, et al.
Oncogene|October 15, 2013
HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptaseC-H Tsai, C-H Teng, Y-T Tu, et al.
International Journal of Particle Therapy|February 1, 2023
Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival OutcomesMichael S Rutenberg, Bradford S Hoppe, Jason S Starr, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 30, 2021
Care transitions and social needs: A Geriatric Emergency care Applied Research (GEAR) Network scoping review and consensus statementCameron J Gettel, Corrine I Voils, Alycia A Bristol, et al.
Oncogene|April 4, 2017
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasisC-J Ko, S-W Lan, Y-C Lu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2013
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancerB M Wolpin, E M O'Reilly, Y J Ko, et al.
Physical Review Letters|February 6, 2025
First Direct Search for Light Dark Matter Using the NEON Experiment at a Nuclear ReactorJ J Choi, C Ha, E J Jeon, et al.
Clinical Genitourinary Cancer|July 5, 2014
Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial designG R Pond, J Bellmunt, J E Rosenberg, et al.
Nature Communications|January 5, 2021
Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASHJinrui Dong, Sivakumar Viswanathan, Eleonora Adami, et al.
Practical Radiation Oncology|October 29, 2021
Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive ChemoradiotherapyRobert W Gao, Robert L Foote, Yolanda I Garces, et al.
Pageof 64